Home/Filings/4/0001127602-22-025844
4//SEC Filing

BLAISE LUCILE 4

Accession 0001127602-22-025844

CIK 0000943819other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:20 PM ET

Size

6.0 KB

Accession

0001127602-22-025844

Insider Transaction Report

Form 4
Period: 2022-11-15
BLAISE LUCILE
President, Sleep & RC Business
Transactions
  • Sale

    ResMed Common Stock

    2022-11-15$225.18/sh169$38,0557,335 total
  • Exercise/Conversion

    ResMed Common Stock

    2022-11-15$225.18/sh+516$116,1937,504 total
Footnotes (2)
  • [F1]The transaction was conducted under a Rule 10b5-1 plan.
  • [F2]Includes 72.515 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001938112

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 6:20 PM ET
Size
6.0 KB